Invariant Image Representation Using Novel Fractional-Order Polar Harmonic Fourier Moments.

Continuous orthogonal moments, for which continuous functions are used as kernel functions, are invariant to rotation and scaling, and they have been greatly developed over the recent years. Among continuous orthogonal moments, polar harmonic Fourier moments (PHFMs) have superior performance and strong image description ability. In order to improve the performance of PHFMs in noise resistance and image reconstruction, PHFMs, which can only take integer numbers, are extended to fractional-order polar harmonic Fourier moments (FrPHFMs) in this paper. Firstly, the radial polynomials of integer-order PHFMs are modified to obtain fractional-order radial polynomials, and FrPHFMs are constructed based on the fractional-order radial polynomials; subsequently, the strong reconstruction ability, orthogonality, and geometric invariance of the proposed FrPHFMs are proven; and, finally, the performance of the proposed FrPHFMs is compared with that of integer-order PHFMs, fractional-order radial harmonic Fourier moments (FrRHFMs), fractional-order polar harmonic transforms (FrPHTs), and fractional-order Zernike moments (FrZMs). The experimental results show that the FrPHFMs constructed in this paper are superior to integer-order PHFMs and other fractional-order continuous orthogonal moments in terms of performance in image reconstruction and object recognition, as well as that the proposed FrPHFMs have strong image description ability and good stability.

A partial encryption algorithm for medical images based on quick response code and reversible data hiding technology.

BACKGROUND: Medical image data, like most patient information, have a strong requirement for privacy and confidentiality. This makes transmitting medical image data, within an open network, problematic, due to the aforementioned issues, along with the dangers of data/information leakage. Possible solutions in the past have included the utilization of information-hiding and image-encryption technologies; however, these methods can cause difficulties when attempting to recover the original images. METHODS: In this work, we developed an algorithm for protecting medical image key regions. Coefficient of variation is first employed to identify key regions, a.k.a. image lesion areas; then additional areas are processed as blocks and texture complexity is analyzed. Next, our novel reversible data-hiding algorithm embeds lesion area contents into a high-texture area, after which an Arnold transformation is utilized to protect the original lesion information. After this, we use image basic information ciphertext and decryption parameters to generate a quick response (QR) code used in place of original key regions. RESULTS: The approach presented here allows for the storage (and sending) of medical image data within open network environments, while ensuring only authorized personnel are able to recover sensitive patient information (both image and meta-data) without information loss. DISCUSSION: Peak signal to noise ratio and the Structural Similarity Index measures show that the algorithm presented in this work can encrypt and restore original images without information loss. Moreover, by adjusting the threshold and the Mean Squared Error, we can control the overall quality of the image: the higher the threshold, the better the quality and vice versa. This allows the encryptor to control the amount of degradation as, at appropriate amounts, degradation aids in the protection of the image. CONCLUSIONS: As shown in the experimental results, the proposed method allows for (a) the safe transmission and storage of medical image data, (b) the full recovery (no information loss) of sensitive regions within the medical image following encryption, and (c) meta-data about the patient and image to be stored within and recovered from the public image.

Development of a support vector machine learning and smart phone Internet of Things-based architecture for real-time sleep apnea diagnosis.

BACKGROUND: The breathing disorder obstructive sleep apnea syndrome (OSAS) only occurs while asleep. While polysomnography (PSG) represents the premiere standard for diagnosing OSAS, it is quite costly, complicated to use, and carries a significant delay between testing and diagnosis. METHODS: This work describes a novel architecture and algorithm designed to efficiently diagnose OSAS via the use of smart phones. In our algorithm, features are extracted from the data, specifically blood oxygen saturation as represented by SpO2. These features are used by a support vector machine (SVM) based strategy to create a classification model. The resultant SVM classification model can then be employed to diagnose OSAS. To allow remote diagnosis, we have combined a simple monitoring system with our algorithm. The system allows physiological data to be obtained from a smart phone, the data to be uploaded to the cloud for processing, and finally population of a diagnostic report sent back to the smart phone in real-time. RESULTS: Our initial evaluation of this algorithm utilizing actual patient data finds its sensitivity, accuracy, and specificity to be 87.6%, 90.2%, and 94.1%, respectively. DISCUSSION: Our architecture can monitor human physiological readings in real time and give early warning of abnormal physiological parameters. Moreover, after our evaluation, we find 5G technology offers higher bandwidth with lower delays ensuring more effective monitoring. In addition, we evaluate our algorithm utilizing real-world data; the proposed approach has high accuracy, sensitivity, and specific, demonstrating that our approach is very promising. CONCLUSIONS: Experimental results on the apnea data in University College Dublin (UCD) Database have proven the efficiency and effectiveness of our methodology. This work is a pilot project and still under development. There is no clinical validation and no support. In addition, the Internet of Things (IoT) architecture enables real-time monitoring of human physiological parameters, combined with diagnostic algorithms to provide early warning of abnormal data.

Excited-state E → Z photoisomerization mechanism unveiled by ab initio nonadiabatic molecular dynamics simulation for hemithioindigo-hemistilbene.

The Zhu-Nakamura formulas based on on-the-fly trajectory surface hopping dynamics simulations at the two-state-averaged CASSCF level were employed to investigate the E → Z photoisomerization mechanisms of hemithioindigo-hemistilbene (HTI) upon S1 excitation. Seven conical intersections were observed along the isomerization pathways, which were composed of double bond torsion, benzene ring torsion, inversion and pyramidalization motions, and only three of them were found to play a role in the dynamics simulations started at S1E-HTI. The dominant isomerization pathway proceeds via central double bond torsion together with pyramidal and tilt motions to some extent (hop via CI5) and accounts for all the reactive trajectories. On the other hand, the two pathways that involve the conical zones lie in the vicinity of the E-form Franck-Condon region (CI7) and proceed along the combined central double bond and benzene ring torsion route (CI3/CI4) with generation of the E products. Within the 332 simulated trajectories, 66 hop to the ground state and only 19 switch to the Z product. The estimated quantum yield of 0.057 (19 in 332) agrees well with the reported experimental value of 0.053 ± 0.016. The excited-state lifetimes span a wide region from hundreds of femtoseconds to several picoseconds, depending on the time for vibrational relaxation and number of cycles for periodical mixed mode torsion.

The effect of trimetazidine treatment in patients with type 2 diabetes undergoing percutaneous coronary intervention for AMI.

PURPOSE: Trimetazidine (TMZ) improves clinical outcomes in patients with chronic heart failure and stable coronary artery disease. No study has yet evaluated the efficacy of TMZ in type 2 diabetes patients with acute myocardial infarction (AMI) undergoing Percutaneous Coronary Intervention (PCI). We performed this study to evaluate the efficacy TMZ in DM patients with AMI undergoing PCI, such as the effect on reductions in myocardial enzyme, improvements in liver function, modulation of glucose levels, and improvement in cardiac function. METHODS: For this randomized study, we enrolled 173 AMI patients with type 2 diabetes undergoing PCI between January 1, 2014, and January 1, 2016. All patients received aspirin and ticagrelor upon admission and throughout their hospitalization. Patients in the experimental group were treated with a loading dose of 60mg TMZ at admission, and 20 mg TMZ three times a day thereafter. 89 patients were included in experimental group, and 84 patients were included in control group. All patients received PCI treatments. The endpoints evaluated were serum creatine kinase and its isoenzyme (CK and CK-MB), cardiac troponin I (cTNI), serum creatinine (Cr), serum urea, blood glucose, serum glutamic pyruvic transaminase (ALT), serum glutamic oxaloacetictransaminase (AST), left atrial dimension (LA), left ventricular ejection fraction (LVEF), left ventricular end-diastolic dimension (LVEDD), and cardiac output (CO). FINDINGS: Compared with the control group, TMZ treatment significantly reduced CK and CK-MB on the second day in hospital ([797±582] vs. [1092±1114]; [80±60] vs. [105±100]; p=0.029, p=0.041, respectively), and cTNI after one and six days in hospital ([13.5±12.7] vs. [19.8±19.2]; [3.3±3.2] vs. [4.8±4.7]; two-tailed p=0.012). In addition, TMZ significantly lowered liver enzymes (ALT, AST) at 6days ([29.0±11.6] vs. [42.4±24.5]; [39.8±17.3] vs. [69.2±70.0]; two-tailed p=0.000), lowered glucose after 6days ([6.80±2.12] vs. [7.59±2.24]; p=0.019), and increased LVEF after ten to fourteen days ([58.4±8.6] vs. [54.9±8.4]; p=0.008). There were no significant effect on Cr and serum urea (p=0.988, p=0.569, respectively), nor on LA, LVEDD, and CO ([36.3±4.5] vs. [37.0±4.1], p=0.264; [52.0±4.9] vs. [53.1±4.6], p=0.128; [5.4±0.9] vs. [5.4±0.9], p=0.929, respectively). IMPLICATIONS: Among type 2 diabetic patients with AMI undergoing PCI, TMZ significantly reduces serum myocardial enzyme, improves liver function, adjusts blood glucose and improves cardiac function.

Diel rhythms of sexual behavior and pheromone titers in Isoceras sibirica Alpheraky (Lepidoptera, Cossidae).

The adult behavior and sex pheromone titers of Isoceras sibirica Alpheraky (Lepidoptera, Cossidae) were investigated to determine the diel periodicity of pheromone production during one scotophase and the effect of age on pheromone production. The results showed that females began to call on the first night after eclosion and called mainly during the second half of scotophase. The percentage of females calling was highest in 1- to 3-day-old females and lowest in 4- to 5-day-old females. The onset of scotophase calling occurred earlier as females aged. The responses to the pheromone source of males aged 1-5 days were monitored in a wind tunnel. Peak activity was observed in 3-day-old males, 4 h after the onset of the scotophase. The mating of all 1- to 3-day-old moths began after 6 h in scotophase and some 4- to 5-day-old moths began during the fourth hour. The average duration of copulation was 34.2 ± 18.2 min (N = 45) and ranged from 17.0 to 56.3 min. Gas chromatography-mass spectrometry (GC-MS) analysis of hexane extracts of pheromone glands revealed that the titers of the three sex pheromone components, (Z)-9-tetradecenyl acetate (Z9-14:Ac), (Z)-7-tetradecenyl acetate, and (Z)-9-hexadecadecenyl acetate were very low on the first night after eclosion, increased and peaked on the second night, then decreased with age. During the first 4 h of the scotophase, titers remained invariant, whereas from 4 to 6 h, pheromone titers increased sharply and peaked, with the greatest peak observed in the primary component, Z9-14:Ac. After the peak, all recorded titers declined until they reached a minimum between the ninth and tenth hours of the dark cycle. In field tests, most of the males were captured in traps during 00:00-02:00 h (13 ± 0.48), and females aged 2 days attracted more males than females of other ages. We infer that the I. sibirica mating system is organized around circadian control of mate calling and mating.

hsa-MicroRNA-28-5p Inhibits Diffuse Large B-Cell Lymphoma Cell Proliferation by Downregulating 14-3-3ζ Expression.

MicroRNAs (miRNAs) participate in the comprehensive biological process of several cancer types. In our former study, we found that hsa-microRNA- (miR-)28-5p was downregulated, but tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activating protein zeta (14-3-3ζ or YWHAZ) was upregulated in diffuse large B-cell lymphoma (DLBCL) tissues. We predicted that YWHAZ was a target gene for hsa-miR- 28-5p using bioinformatics analysis. Our goal was to reveal the role of hsa-miR-28-5p in DLBCL. YWHAZ was tested by immunohistochemistry (IHC) in formalin-fixed paraffin-embedded (FFPE) tissues of 137 DLBCL tissues, and the expression of hsa-miR-28-5p and YWHAZ was examined by quantitative real-time polymerase chain reaction (qRT-PCR) in 15 fresh and frozen DLBCL tissues. To study the functional roles of the downregulated hsa-miR-28-5p in DLBCL, a Cell Counting Kit-8 assay was conducted to estimate cell proliferation. Transient transfection of miRNA mimics was performed to overexpress hsa-miR-28-5p, and flow cytometry was performed to examine cell apoptosis and cell cycle progression. A dual-luciferase reporter assay was employed to explore the relationship between hsa-miR-28-5p and YWHAZ. Western blotting and qRT-PCR were used to investigate the function of hsa-miR-28-5p in YWHAZ expression. hsa-miR-28-5p was found to be significantly downregulated in DLBCL tissues and cell lines. Functional studies showed that hsa-miR-28-5p overexpression inhibited cell viability and proliferation, and YWHAZ was predicted to be a target of hsa-miR-28-5p. Dual-luciferase reporter assay, Western blotting, and qRT-PCR verified that hsa-miR-28-5p negatively regulated YWHAZ expression by directly targeting its 3' untranslated regions in DLBCL cells. hsa-miR-28-5p may suppress the growth of DLBCL cells by inhibiting YWHAZ expression. These findings could provide novel targets for DLBCL diagnosis and therapy.

Analysis of the Clinicopathologic Characteristics and Prognosis of Head and Neck Lymphoma.

Statistical reports on non-Hodgkin's lymphoma (NHL) of the head and neck combining clinical medicine with pathology are rare. To provide a basis for prognosis prediction and individualized treatment, we will investigate the clinicopathologic characteristics and prognosis of lymphoma in the head and neck region. Four hundred sixty-one patients with NHL in the head and neck region diagnosed through histological biopsy were retrospectively analyzed. Fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) were performed in all cases to evaluate the genetic status and protein expression levels. Patients were followed up by telephone. The prevalence rate of primary extranodal NHL (PENHL) in the head and neck region was 44.62% (166/372). The incidence of extranodal lymphoma accounted for 36.66% (169/461) of all head and neck lymphomas. Among the cases of PENHL of the head and neck, diffuse large B-cell lymphoma (DLBCL) (60/76, 78.95%) and extranodal NK/T-cell lymphoma, nasal type (ENKTCL) (21/24, 87.5%) were the most common subtypes originating from B-cell lymphoma (BCL) and T-cell lymphoma (TCL), respectively. The most common sites of nodal and extranodal onset were neck lymph nodes and the gastrointestinal tract, respectively. The most common and primary locations of BCL and TCL were the tonsils and nasal cavity, respectively. The 3-year survival rates of PENHL, ENKTCL, and DLBCL of the head and neck were 42%, 28.57%, and 41.67%, respectively, and the 5-year survival rates were 24%, 19.05%, and 20%, respectively. Survival analysis showed that male sex was a risk factor (HR = 5.421; 95% CI, 1.164-25.267; p < 0.05) and that comprehensive treatment was a protective factor (HR = 0.117; 95% CI, 0.025-0.545; p < 0.05) against extranodal DLBCL in the head and neck region. Bone marrow involvement was a risk factor for PENHL of the head and neck (HR = 5.072; 95% CI, 1.17-21.991; p < 0.05). The purpose of this review is to show that PENHL of the head and neck with high incidence deserves more attention, and a model of multidisciplinary diagnosis and treatment should be adopted.

Correlation study of PD-L1, CD4, CD8, and PD-1 in primary diffuse large B-cell lymphoma of the central nervous system.

We investigated the clinicopathological role of the PD-1/PD-L1 pathway in the primary diffuse large B-cell lymphoma of the central nervous system (PCNS-DLBCL). Standardized staining for PD-L1 was performed by machine staining, and internationally accepted interpretation methods were used. The PD-L1 immunostaining ≥ 20 % of all cells in slices was defined as high expression of PD-L1. CD4, CD8, and PD-1 tumor-infiltrating lymphocytes (TILs) were enumerated, and the median was defined as the cutoff value. Values higher than the median was defined as high expression. Thirty-four cases (64.2 %) showed high expression of PD-L1. PD-L1 expression was associated with a good prognosis when 20 % was considered as cutoff value and had the smallest P value. By contrast, a low number of CD8+ or PD-1+ TILs was associated with poor prognosis. Patients with low expression of PD-L1 had poor overall survival (P = 0.001), and those with increased CD8 or PD-1 TILs tended to have improved overall survival (P = 0.004 and 0.024, respectively). Low number of monocytes, increased number of lymphocytes, IPI score ≥ 2, ECOG PS ≥ 2, LDH ≥ 250, and Ki67 ≥ 70 % were independent prognostic factors for OS. In conclusion, PD-L1 expression, CD8 and PD-1 TILs, monocyte status, and ECOG PS might be prognostic markers and therapeutic targets of PCNS-DLBCL.

Expression and prognostic analysis of STAT6(YE361) in Hodgkin lymphoma.

This study aimed to investigate the expression and prognostic significance of the signal transducer and activator of transcription protein 6 (STAT6YE361) and EB virus encoding a small molecule RNA (EBER) in Hodgkin lymphoma (HL), as well as their correlation with clinical parameters. The expression of STAT6YE361 and EBER was investigated in HL via immunohistochemistry and in situ hybridization. Patient clinical data were retrospectively collected from archival libraries, and statistical analysis was performed. Overall, the nuclear positive expression rate of STAT6YE361 was 46%, and the EBER positive expression rate was 57%. STAT6YE361 was specifically expressed on the nucleus in cHL tissues. EBER was overexpressed in HL and had correlations with several clinical data, including age, gender, ethnicity, and primary cancer site. Interestingly, nuclear STAT6YE361 expression was correlated with EBER expression. Based on survival analysis, the nuclear expression of STAT6YE361 and female patients were associated with poor prognosis and were independent prognostic factors for five-year OS. These findings suggest that STAT6YE361 is a potential valuable index in the differential diagnosis and prognosis of HL. The mechanism of STAT6YE361 is related to Epstein-Barr virus infection.

The sex pheromone of the sand sagebrush carpenterworm, Holcocerus artemisiae (Lepidoptera, Cossidae).

(Z)-5-dodecen-1-ol (Z5-12:OH), (Z)-5-dodecenyl acetate (Z5-12:Ac), and (Z)-5-tetradecenyl acetate (Z5-14:Ac) were found in the extracts of the female sex pheromone gland of the carpenterworm moth Holcocerus artemisiae Chou et Hua, a pest of Artemisia filifolia. The average amounts of Z5-12:OH, Z5-12:Ac, and Z5-14:Ac in a single sex pheromone gland of a calling moth were (7.14 +/- 0.73) ng, (54.20 +/- 0.34) ng, and (38.70 +/- 0.46) ng, respectively. Electroantennography (EAG) of these compounds and their analogues demonstrated that Z5-12:Ac excitated the largest male EAG response, followed by Z5-14:Ac. Traps baited with rubber septa impregnated with Z5-12:Ac (500 microg/septum) and Z5-14:Ac (300 microg/septum) were more effective than traps with other baits or virgin females. Addition of Z5-12:OH to rubber septa did not enhance the trap catches, but (E,Z)-3,5-dodecadienyl acetate (E3,Z5-12:Ac) enhanced the trap catch.